Informed investment: Niche tech company 'moves up the food chain'

Investors continue to throw support to InformedDNA, a St. Petersburg tech firm that provides genetic test analysis services to health insurers.

As previously reported, the company has attracted $24 million in funding since it was launched in 2007. A key point came in 2013 when it changed its target market from individual end users to insurance companies, which face rising demand for services related to precision medicine, which tailors treatment plans based on a person’s unique gene code.